• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home Wellness

Nature exposure during exercise and nature therapy may improve mental health

byKiera LiblikandAvneesh Bhangu
October 12, 2021
in Wellness
Reading Time: 2 mins read
Parents often unaware of adolescents’ suicidal thoughts
Share on FacebookShare on Twitter

1. In this prospective study, the impact of exercise in nature and nature therapy was measured in young adults who reported feelings of anxiety, depression, and stress during the COVID-19 pandemic.

2. Both nature therapy and exercise in nature resulted in improved mental health, although nature therapy had a greater positive effect.

Evidence Rating Level: 3 (Average)

Lockdown measures during the COVID-19 pandemic have been associated with increases in stress, anxiety, and depression. Nature therapy and frequent exposure to nature may improve mental health in those experiencing negative mental health outcomes during isolation periods.

This prospective study evaluated changes in mental wellbeing associated with nature exposure during exercise and nature therapy during the COVID-19 pandemic. Participants were randomized to either a nature-exercise (perform physical exercise in a nature setting) or nature therapy group. The nature-exercise and nature therapy groups followed specific programming. Inclusion criteria included adults aged 18-40 who reported increased depression, anxiety, and stress associated with the COVID-19 pandemic. Participants were excluded if they did not have access to an urban greenery. Study outcomes evaluated the mental health status of participants pre- and post-intervention using the depression, anxiety, and stress scale – 21 items (DASS-21).

A total of 30 participants were included, 15 in each group. Participants who lived in regions with severe lockdown measures reported worse mental health at baseline. Overall, both nature-exercise and nature therapy were associated with significant improvements in stress, anxiety, and depression. Although, nature therapy was more effective in improving mental health status. The present study was limited due to small sample size, lack of control group, and because participants were not monitored during activities for compliance to programming. Nonetheless, this study suggested that nature exposure may represent an inexpensive means of improving mental health, particularly during COVID-19.

RELATED REPORTS

Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome

Video mental health care may have clinical advantages versus phone or in-person visits

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

Click to read the study in Urban Forestry & Urban Greening

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anxietydepressionexercisemental healthnaturenature therapystresstherapywellness
Previous Post

Role of endoscopic ultrasonography for differential diagnosis of upper gastrointestinal submucosal lesions

Next Post

Increasing the number of SARS-CoV-2 immune family members associated with decreasing risk of infection in nonimmune individuals

RelatedReports

Chronic Disease

Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome

September 28, 2026
Chronic Disease

Video mental health care may have clinical advantages versus phone or in-person visits

September 12, 2026
Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Artificial Intelligence

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

September 9, 2026
Next Post
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Increasing the number of SARS-CoV-2 immune family members associated with decreasing risk of infection in nonimmune individuals

Parental hopes for critically ill children are dynamic

Experience with providing ECMO support may influence COVID-19 related mortality

Asymptomatic women at high risk for Multiple Sclerosis may have early subclinical neuroimaging abnormalities

Factors associated with earlier clinical symptom onset in radiologically isolated multiple sclerosis

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome
  • 2 Minute Medicine Rewind September 28, 2026
  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.